CreditRiskMonitor is a financial risk analysis and news service for credit, supply chain and financial professionals.  Our strength in coverage spans 58,000 global public companies, totaling about $70 trillion in corporate revenue.  We also offer solutions that can help ease private company financial risk assessment.  Leading corporations around the world – including more than 35% of the Fortune 1000, plus thousands more worldwide – rely on us to help them stay ahead of financial risk quickly, accurately and cost-effectively. 

A partial report preview for Biocompatibles International plc is shown below.  Where indicated by "Yes," CreditRiskMonitor contains this information in its extensive database.  To get access to the full report and learn more about CreditRiskMonitor's robust financial risk analysis and timely news service, request a personalized demo and free trial today.

If you are already a subscriber and want to access the full report, click here.

Biocompatibles International plc
Chapman House Farnham Business Park Weydon Lane Farnham
Phone: +44 1252 732 732p:+44 1252 732 732 Surrey, GU9 8QL  United Kingdom Fax: +44 1252 732 777f:+44 1252 732 777

This company is no longer actively traded on any major stock exchange.
This is a Subsidiary, click here for the Parent Company

Business Summary
Biocompatibles International plc is a medical technology company focused on drug device Combination Products for use in Oncology Products Division and Licensing Division. Under Oncology Products Division it has two products: Bead Products and BrachySciences. Under Licensing Division it has two products: CellMed and PC Licensing. The Oncology Products Division conducts the marketing of the Company’s approved oncology products. These include Drug-Eluting Bead products, which are used for the treatment of primary liver cancer (HCC), liver metastases from colo-rectal cancer, and other cancers, and Brachytherapy products (radiation-delivering seeds), which are used in the treatment of prostate cancer. Its subsidiaries include Biocompatibles UK Limited, Biopolymerix Inc., Biocompatibles Inc., and CellMed AG. These are engaged in Commercialization of Bead products, Research and development, and Commercialization of Brachytherapy products. It acquired Astron Clinica Limited in November 2009.
(Source: ARS)

Scores and Ratings
FRISK®
Score
Z''
Score
PAYCE®
Score
DBT
Index
Moody's
Rating
Fitch
Rating
DBRS
Rating
-Yes-----

Financials, News and Filings
Latest
Statement
Last
Audit

News
SEC
Filings
Bankruptcy
Filings
Suit &
Judgment
Filings
Tax
Lien
Filings
6/30/201012/31/2009Yes----

Officers and Directors

Title

Name

Age
Title
Date
Start
Date
Non-Executive Chairman of the Board E. Gerry F.Brown 65 6/22/2006 1/10/2006
Chief Executive, Executive Director CrispinSimon 52
Chairman of BrachySciences, USA GaryLamoureux
12 additional Officers and Directors records available in full report.

Business Names
Business Name
Astron Clinica Limited
BII
Biocompatibles Inc.
5 additional Business Names available in full report.

General Information
Number of Employees: 164 (As of 12/31/2009)
Outstanding Shares: 39,357,374 (As of 10/28/2010)
Shareholders: 51,467
Stock Exchange: LON
Fax Number: +44 1252 732 777


Copyright © 2023 CreditRiskMonitor.com (Ticker: CRMZ). All rights reserved.     
By using this website, you accept the Terms of Use Agreement.
Saturday, July 22, 2023